Standard BioTools
LAB
LAB
84 hedge funds and large institutions have $227M invested in Standard BioTools in 2018 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 27 increasing their positions, 28 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 15
4% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 28
Holders
84
Holding in Top 10
1
Calls
$189K
Puts
$131K
Top Buyers
| 1 | +$4.08M | |
| 2 | +$2.94M | |
| 3 | +$897K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$743K |
| 5 |
Renaissance Technologies
New York
|
+$704K |
Top Sellers
| 1 | -$1.27M | |
| 2 | -$849K | |
| 3 | -$630K | |
| 4 |
Millennium Management
New York
|
-$564K |
| 5 |
Morgan Stanley
New York
|
-$521K |